Evidence map›Paper›PMID 27755393›Full record

ArticleMedical care2017

Prescriber Continuity and Disease Control of Older Adults.

Matthew L Maciejewski, Bradley G Hammill, Elizabeth A Bayliss, Laura Ding, Corrine I Voils, Lesley H Curtis, Virginia Wang

Abstract read
In one paragraph

Article in Medical care, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Examining Factors Associated With Nonadherence And Identifying Providers Caring For Nonadherent Subgroups.Journal of pharmaceutical health services research : an official journal of the Royal Pharmaceutical Society of Great Britain · 2017
    Article
  17. Article
  18. Fragmented Ambulatory Care and Medication Count among Older Adults.American journal of medical quality : the official journal of the American College of Medical Quality
    Article
  19. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Matthew L Maciejewski*Center for Health Services Research in Primary Care, Durham Veterans Affairs Medical Center †Department of Medicine, Division of General Internal Medicine ‡Duke Clinical Research Institute, Duke University Medical Center, Durham, NC §Institute for Health Research, Kaiser Permanente Colorado, Denver ∥Department of Family Medicine, University of Colorado Denver, Aurora, CO ¶Department of Biostatistics and Bioinformatics, Duke University, Durham, NC.
Bradley G Hammill
Elizabeth A Bayliss
Laura Ding
Corrine I Voils
Lesley H Curtis
Virginia Wang

Funding

Fragmentation of Medication Management in MedicareR01HS023085 · AHRQ · DUKE UNIVERSITY · PI MACIEJEWSKI, MATTHEW L · 2014 to 2014
$377k
AHRQ HHS R01 HS023085HSRD VA IK6 HX003157
6 · The paper itself

Abstract

backgroundMedicare beneficiaries with multiple chronic conditions are typically seen by multiple providers, particularly specialists. Clinically appropriate referrals to multiple specialists may compromise the continuity of care for multiple chronic condition beneficiaries and create care plans that patients may find challenging to reconcile, which may impact patient outcomes.

objectiveThe objective was to examine whether glycemic control or lipid control was associated with the number of prescribers of cardiometabolic medications. RESEARCH DESIGN, SUBJECTS, AND MEASURES: A retrospective cross-sectional cohort analysis of 51,879 elderly Medicare fee-for-service beneficiaries with diabetes and 129,762 beneficiaries with dyslipidemia living in 10 east coast states. Glycemic control was defined as having an HbA1c<7.5. Lipid control was defined as an low-density lipoprotein<100 for beneficiaries with heart disease or diabetes or an low-density lipoprotein<130 for all other beneficiaries. We examined the association between the number of prescribers of cardiometabolic medications and disease or lipid control in 2011 through logistic regression, controlling for age, sex, race, Medicaid enrollment, 17 chronic conditions and state-fixed effects.

resultsAmong beneficiaries with diabetes, 76% with one prescriber had well-controlled diabetes in 2011, which decreased to 65% for beneficiaries with 5+ prescribers. In adjusted analyses, Medicare beneficiaries with 3 or more prescribers were less likely to have glycemic control than beneficiaries with a single prescriber. Among those with dyslipidemia, nearly all (91%-92%) beneficiaries had lipid control. After adjustment for demographics and comorbidity burden, beneficiaries with 3 prescribers were less likely to have lipid control than beneficiaries with a single prescriber.

conclusionsMultiple prescribers were associated with worse disease control, possibly because patients with more severe diabetes or dyslipidemia have multiple prescribers or because care fragmentation is associated with worse disease control.

Indexed as

Medication Therapy ManagementAgedAged, 80 and overComorbidityContinuity of Patient CareCross-Sectional StudiesDiabetes MellitusDisease ManagementDrug MonitoringDyslipidemiasFemaleHumansHypoglycemic AgentsHypolipidemic AgentsMaleMedicareHypoglycemic AgentsHypolipidemic Agents

Identifiers

PMID27755393
PMCPMC5352484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.